ARCHIVES

Centers Program Needs ‘Innovative Additions’ Such as SPORE Grants

This article is from The Cancer Letter archive.

Vol. 17 No. 36 | September 20, 1991

Download PDF Visit The Full Archive

Related Articles

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

Bill Introduced To Curb NIH Use Of Title 42 Salaries

August 10, 2012

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

Tykerb Plus Letrozole Delayed Metastatic Breast Cancer

January 30, 2009

In Brief: NIDR, NCI award $2.8 Million In Grants For Oral Cancer research Centers

October 4, 1996

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001